Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TRPC6 pseudogene 3 (TRPC6P3) is a noncoding pseudogene related to the TRPC6 gene, which encodes a receptor-activated cation channel implicated in calcium signaling in podocytes and cardiac tissue. TRPC6P3 does not encode a functional ion channel or any protein product, and is not considered a therapeutic target. Its biological role, if any, remains uncharacterized. The information available pertains solely to its classification as a pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transient receptor potential cation channel subfamily C member 6 pseudogene 3 (TRPC6P3).